271 related articles for article (PubMed ID: 24280701)
1. Applications of cell-penetrating peptides for tumor targeting and future cancer therapies.
Regberg J; Srimanee A; Langel U
Pharmaceuticals (Basel); 2012 Sep; 5(9):991-1007. PubMed ID: 24280701
[TBL] [Abstract][Full Text] [Related]
2. Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides.
Dissanayake S; Denny WA; Gamage S; Sarojini V
J Control Release; 2017 Mar; 250():62-76. PubMed ID: 28167286
[TBL] [Abstract][Full Text] [Related]
3. Cell-penetrating peptides: achievements and challenges in application for cancer treatment.
Shin MC; Zhang J; Min KA; Lee K; Byun Y; David AE; He H; Yang VC
J Biomed Mater Res A; 2014 Feb; 102(2):575-87. PubMed ID: 23852939
[TBL] [Abstract][Full Text] [Related]
4. Cell-Penetrating Peptides: Applications in Tumor Diagnosis and Therapeutics.
Stiltner J; McCandless K; Zahid M
Pharmaceutics; 2021 Jun; 13(6):. PubMed ID: 34204007
[TBL] [Abstract][Full Text] [Related]
5. Improved breast cancer cell-specific intracellular drug delivery and therapeutic efficacy by coupling decoration with cell penetrating peptide and SP90 peptide.
Fan LQ; Du GX; Li PF; Li MW; Sun Y; Zhao LM
Biomed Pharmacother; 2016 Dec; 84():1783-1791. PubMed ID: 27899251
[TBL] [Abstract][Full Text] [Related]
6. Cell-penetrating peptides: strategies for anticancer treatment.
Raucher D; Ryu JS
Trends Mol Med; 2015 Sep; 21(9):560-70. PubMed ID: 26186888
[TBL] [Abstract][Full Text] [Related]
7. Cell-Penetrating Peptides for Antiviral Drug Development.
Delcroix M; Riley LW
Pharmaceuticals (Basel); 2010 Mar; 3(3):448-470. PubMed ID: 27713263
[TBL] [Abstract][Full Text] [Related]
8. Effect of small molecule signaling in PepFect14 transfection.
Gestin M; Helmfors H; Falato L; Lorenzon N; Michalakis FI; Langel Ü
PLoS One; 2020; 15(1):e0228189. PubMed ID: 31999754
[TBL] [Abstract][Full Text] [Related]
9. Acid-sensitive hybrid polymeric micelles containing a reversibly activatable cell-penetrating peptide for tumor-specific cytoplasm targeting.
Tang B; Zaro JL; Shen Y; Chen Q; Yu Y; Sun P; Wang Y; Shen WC; Tu J; Sun C
J Control Release; 2018 Jun; 279():147-156. PubMed ID: 29653223
[TBL] [Abstract][Full Text] [Related]
10. The world of cell penetrating: the future of medical applications.
Falanga A; Lombardi L; Galdiero E; Genio VD; Galdiero S
Future Med Chem; 2020 Aug; 12(15):1431-1446. PubMed ID: 32723097
[TBL] [Abstract][Full Text] [Related]
11. Angiopep-2 and activatable cell penetrating peptide dual modified nanoparticles for enhanced tumor targeting and penetrating.
Mei L; Zhang Q; Yang Y; He Q; Gao H
Int J Pharm; 2014 Oct; 474(1-2):95-102. PubMed ID: 25138251
[TBL] [Abstract][Full Text] [Related]
12. [Activatable cell-penetrating peptides: a potential activatable modality for diseases diagnosis and therapy].
Yang SK; Yan X; Sun WH; Du Q; Xiang B; Cao DY; Qi XR
Yao Xue Xue Bao; 2016 Apr; 51(4):529-35. PubMed ID: 29859520
[TBL] [Abstract][Full Text] [Related]
13. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
Reissmann S
J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
[TBL] [Abstract][Full Text] [Related]
14. [The application of enzyme-sensitive activatable cell-penetrating peptides to targeted delivery system].
He F; Cao L; Zhang XJ; Xiang B; Cao DY; Qi XR
Yao Xue Xue Bao; 2015 Feb; 50(2):141-7. PubMed ID: 25975019
[TBL] [Abstract][Full Text] [Related]
15. Peptide-based targeted therapeutics: Focus on cancer treatment.
Araste F; Abnous K; Hashemi M; Taghdisi SM; Ramezani M; Alibolandi M
J Control Release; 2018 Dec; 292():141-162. PubMed ID: 30408554
[TBL] [Abstract][Full Text] [Related]
16. Recent progress of cell-penetrating peptides as new carriers for intracellular cargo delivery.
Wang F; Wang Y; Zhang X; Zhang W; Guo S; Jin F
J Control Release; 2014 Jan; 174():126-36. PubMed ID: 24291335
[TBL] [Abstract][Full Text] [Related]
17. Harnessing the power of cell-penetrating peptides: activatable carriers for targeting systemic delivery of cancer therapeutics and imaging agents.
MacEwan SR; Chilkoti A
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(1):31-48. PubMed ID: 22977001
[TBL] [Abstract][Full Text] [Related]
18. [Application of activatable cell-penetrating peptide in the field of tumor therapy].
Zhang L; Wei G; Lu WY
Yao Xue Xue Bao; 2014 Dec; 49(12):1639-43. PubMed ID: 25920191
[TBL] [Abstract][Full Text] [Related]
19. Cell-penetrating peptides and their analogues as novel nanocarriers for drug delivery.
Jafari S; Maleki Dizaj S; Adibkia K
Bioimpacts; 2015; 5(2):103-11. PubMed ID: 26191505
[TBL] [Abstract][Full Text] [Related]
20. Peptide-based delivery of therapeutics in cancer treatment.
Samec T; Boulos J; Gilmore S; Hazelton A; Alexander-Bryant A
Mater Today Bio; 2022 Mar; 14():100248. PubMed ID: 35434595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
